Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?

Authors

Chou Joshua
Nicole J. Brandt
Feng-Hua Ellen Loh, Touro College of PharmacyFollow
Bruce Stuart

Document Type

Article

Publication Date

2017

Recommended Citation

Chou, J., Brandt, N. J., Loh, F. E., & Stuart, B. (2017). Do restrictions on antipsychotic use differ between Medicare part D stand-alone versus Medicare Advantage plans? Consultant Pharmacist, 32(2), 109-118.

Publisher's Statement

The original material can be found here: http://www.ingentaconnect.com/contentone/ascp/tcp/2017/00000032/00000002/art00008